Trial
NCT02730793
Aztreonam Aerosol to Treat Cystic Fibrosis Nasal Disease
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Virginia Commonwealth University
Collaborators
Eastern Virginia Medical School
Condition
Cystic Fibrosis
Intervention
Oral Aztreonam
Why stopped
terminated due to an inability to recruit study subjects
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-01-28